The safety of calcium channel blockers in human pregnancy: A prospective, multicenter cohort study

L. A. Magee, B. Schick, A. E. Donnenfeld, S. R. Sage, B. Conover, L. Cook, P. R. McElhatton, M. A. Schmidt, G. Koren

Research output: Contribution to journalArticlepeer-review

188 Scopus citations

Abstract

OBJECTIVE: Our purpose was to examine the potential teratogenicity of calcium channel blockers. STUDY DESIGN: Six teratogen information services prospectively collected and followed up 78 women with first-trimester exposure to calcium channel blockers. Pregnancy outcome was compared (by paired t test or χ2 analysis) with that of a control group matched for maternal age and smoking. RESULTS: There was no increase in major malformations (2/66 = 3.0% [calcium channel blockers] vs 0% [nonteratogenic controls], p = 0.27); a fivefold increase was ruled out (baseline 2%, α = 0.05, β = 0.20). The defects reported were attributable to maternal diabetes or coingestion of teratogens. The increase in preterm delivery (28% [calcium channel blockers] vs 9% [nonteratogenic controls], p = 0.003), attributed to maternal disease by stepwise regression, was the most important factor responsible for the observed decrease in birth weight (mean 384 gm vs nonteratogenic controls, p = 0.08). CONCLUSION: This study suggests that calcium channel blockers do not represent a major teratogenic risk.

Original languageEnglish
Pages (from-to)823-828
Number of pages6
JournalAmerican Journal of Obstetrics and Gynecology
Volume174
Issue number3
DOIs
StatePublished - 1996
Externally publishedYes

Keywords

  • Calcium Channel blockers
  • birth weight
  • pregnancy
  • pregnancy complications

Fingerprint

Dive into the research topics of 'The safety of calcium channel blockers in human pregnancy: A prospective, multicenter cohort study'. Together they form a unique fingerprint.

Cite this